Influence of Ferula Hermonis Acetonic Extract on Exercise Adapted Rat Gastrocnemius

Research Article

Austin Cell Biol. 2015; 1(1): 1003.

Influence of Ferula Hermonis Acetonic Extract on Exercise Adapted Rat Gastrocnemius

Allouh MZ* and Said RS

Department of Anatomy, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

*Corresponding author: Mohammed Z Allouh, Department of Anatomy, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Received: December 17, 2015; Accepted: December 30, 2015; Published: December 31, 2015

Abstract

Ferula hermonis boiss is a medicinal plant that grows in the Mediterranean region. It has been reported that treatment with acetonic extract from the root of this plant improves the growth of tibialis anterior muscle fibers when associated with exercise. This study investigated the effects of F. hermonis extract alone or combined with exercise on the morphology of rat Gastrocnemius (GC) muscle fibers. Adult male rats were divided into four groups: Control Sedentary (CS) that had no treatment or exercise; Ferula Sedentary (FS) that was orally treated with ferula extract at a dose of 60 mg/kg every other day over a period of 20 days; Control Exercised (CE) that was trained by swimming for 40 minutes every other day; and Ferula Exercised (FE) that received ferula and performed exercise. At the end of experiments, the fiber diameter, number of muscle nuclei, nuclear length, and nuclear area of GC were measured by using immune fluorescent techniques and software analyses. FE group showed significant increases in nuclear area and nuclear number compared to the other groups. In addition, the fiber diameter increased significantly in FE group compared to CS group. In conclusion, short term exercise combined with administration of F. hermonis extract was more effective in enhancing the growth of GC muscle fibers than exercise alone.

Keywords: Ferula; Skeletal muscle fiber; Muscle nuclei; Testosterone

Abbreviations

CS: Control Sedentary; CE: Control Exercised; FS: Ferula Sedentary; FE: Ferula Exercised; GC: Gastrocnemius

Introduction

Ferula hermonis (Boiss.) is a medicinal plant that belongs to the apiaceae family and grows abundantly in the Middle East [1,2]. The root extract of this plant is commonly used as a treatment for sexual impotence. Recently, the root extract has been commercialized and is widely used among Middle Eastern populations to improve performance and increase energy [3]. Several phytochemical and pharmaceutical studies were conducted on this plant to identify its active ingredients and their respective mechanism of action [4,5]. The main ingredients are four aromatic esters of sesquiterpene alcohol known as ferutin in (ferutinolp hydroxyl benzoate), teferd in (ferutinol benzoate), tefer in (ferutinolvanillate) and epoxybenz (epoxyferutinol benzoate) [4]. In addition to these esters, several naturally occurring vitamins and minerals were found in the root of F. hermonis [1].

In a previous study we reported that oral administration of acetonic extract from F. hermonis can increase serum testosterone levels and augment the effect of exercise on rat tibialis anterior muscle [3]. The rat tibialis anterior muscle is predominantly composed of glycolytic type of fibers (type IIb) [6,7]. This study aimed to investigate the reproducibility of the effect of acetonic root extract of F. hermonis on Gastrocnemius (GC) deep muscle fibers, since this portion of the muscle is composed of different fiber types (type I and type IID) [7,8]. The study tested the hypothesis that supplementation of F. hermonis extract combined with short term exercise is more effective in improving GC muscle fiber growth than exercise alone.

Materials and Methods

Experimental model

Adult male albino rats of Sprague Dawleys train, weighing about 300 g, were produced and raised in the Animal House Unit at Jordan University of Science and Technology (JUST) for this study. All animal care procedures and treatments were conducted with the approval of the Animal Care Unit Committee at JUST, and according to the guidelines of the National Institute of Health on the use and care of laboratory animals (USA).

The rats were divided randomly into four groups: Control Sedentary (CS) that had no treatment or exercise, ferula sedentary (FS) that was orally treated with ferula extract, Control Exercised (CE) that was trained by swimming, and ferula exercised (FE) that received combined treatment and exercise. Each group contained three male rats. The animals were kept under controlled temperature of 21 ±1°C with a schedule of 12 hours light and 12 hours dark (lights on 06.00–18.00 hr). Food and water were available ad libitum. The rats were given a two week adaptation period before starting the treatment.

Extract preparation and animal treatments

F. hermonis roots were obtained from a local market in Jordan and further identified by specialized botanists in The Department of Biological Sciences at Yarmouk University, Jordan. The roots were ground into powder and the acetonic extract was prepared using a Soxhlet apparatus. The extract was then filtered and the solvent from the filtrate was removed by distillation. The remaining solid extract was preserved in a refrigerator until treatment.

Just before treatment, the extract was solubilized in Tween 80 (10%) and distilled water (90%) to facilitate its oral administration to the animals in the ferula treated groups at a dose of 60 mg/kg body weight. This dose was similar to the one administered in our previous study [3]. The dose was given every other day using animal feeding intubation needles (Popper & Sons, NY, USA). Each animal received ten doses over a period of twenty days. Animals in the control groups received the same volume of vehicle media only.

Swimming exercise

Rats in the exercised groups were trained to swim in a rectangular water tank (1.5 x 1.0 m) with a water depth of40 cm and a temperature of approximately 34 36°C. Swimming was selected as the mode of exercise because it is considered to be less traumatic for the animals and does not cause foot injures. The swimming protocol was conducted in two phases: adaptation and training. The adaptation phase started in the last five days of the acclimatization period, before the treatments began. The rats were exposed for 10 min swimming on the first day of adaptation. The swimming period was extended by 10 minutes every day until the rats were swimming for a total of 40 min. On the final day of the adaptation phase, the animals were allowed to rest. The training phase consisted of swimming for 40 min on the same day of ferula treatment, 45 min after receiving the oral dose. The rats were trained 10 sessions over a period of 20 days. All swimming sessions were supervised to avoid floating and/or clinging of the rats.

Testosterone assay

The rats were euthanized by diethyl ether and trunk blood was collected into centrifuge tubes. Serum was prepared by centrifugation at 3000 rpm for 30 min, and then stored frozen (40°C) until testosterone assay. The testosterone concentration was determined by using the Testosterone Enzyme Immunoassay test kit (Bio Check Inc., CA, USA). The minimum detectable concentration of this assay was estimated to be 0.05 ng/ml and cross reactivity with other corticosteroids was minimal (<0.05%).

Tissue preparation and sectioning

Muscle samples were excised from the deep portion of the GC muscle of each rat. The samples were cut parallel to the orientation of the muscle fibers. Each sample was then coated with Optimal Cutting Temperature (O.C.T.) compound (Bio Optica, Milano, Italy) and immediately frozen in 2-methylbutane cooled via liquid nitrogen. Samples were then stored at 40°C until sectioning.

Serial cross-sections of 10 μm thickness were cut at -20°C using a cryostat. Every two serial sections were picked up on a Super frost Plus microscopic slide (Santa Cruz Biotechnology Inc., CA, USA). The reason for collecting two sections on each slide was to increase the possibility of choosing better fields for imaging. Serial slides bearing sections were numbered and stored at -20°C.

Antibodies

The primary antibody used for immune staining was antilaminin (Sigma Chemical Co., MI, USA). Anti laminin is a rabbit polyclonal antibody that was developed against the glycoprotein laminin of mouse origin and was used to detect the basal laminae of skeletal muscle fibers at a dilution of 1:200. Tetra methyl rhodamine secondary antibody (Sigma Chemical Co.) was used to label antilaminin in red when viewed with an epifluorescent microscope. The secondary antibody was prepared in phosphate-buffered saline (PBS) at a dilution of 1:400.

Immunocytochemical protocol

Slides were removed from the -40°C and air dried for 15 min. Sections were then treated for 30 min with 200 μl of blocking solution, which consisted of 5mM Ethylene Diamine Tetra Acetic Acid (EDTA) in phosphate-buffered saline (PBS), 5% goat serum and 1% bovine serum albumin. After that, blocking solution was drained from each slide and anti-laminin primary antibody diluted in blocking solution was added to each slide (150μl) and incubated over night at 4°C. Slides were then washed three times in fresh PBS solution for 5 min per wash. The secondary anti body was then applied over the sections on each slide for 40 min at room temperature, followed by two 5 min washes in fresh PBS. Finally, slides were mounted with cover slips using Ultra Cruz mounting medium containing DAPI (Santa Cruz Biotechnology Inc.) and sealed before being examined under epifluorescent microscopy.

Image analysis and data collection

Four different fields of view were captured from each immune fluorescent slide using a fluorescent microscope equipped with a digital camera. Two epifluorescent images, each viewed through a different wavelength filter, were acquired from each field. Images were subsequently transferred to a computer, and the two images of each field of view were superimposed using Adobe Photoshop program (Adobe System Inc., CA, USA). The resultant immune fluorescent images showed all nuclei in blue and basal laminae in red (Figure 1).